ctrl K

Intercept Pharmaceuticals Inc. (ICPT)

NASDAQ: ICPT · Real-Time Price · USD

19.00

0.04 (0.21%)

At close: Nov 07, 2023, 9:00 PM

Intercept Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	285.71M	363.47M	312.69M	252M	179.8M	130.96M	24.95M
Cost of Revenue	984K	3.1M	5.32M	4.21M	2.52M	1.37M	n/a
Gross Profit	284.73M	360.37M	307.37M	247.79M	177.28M	129.59M	24.95M
Operating Income	-68.22M	-55.76M	-216.61M	-312.43M	-285.49M	-335.61M	-402.54M
Interest Income	15.51M	47.77M	39.8M	33.35M	n/a	n/a	n/a
Pretax Income	-174.86M	-91.43M	-274.88M	-344.68M	-309.24M	-360.37M	-412.83M
Net Income	115.17M	-145.02M	-324.23M	-391.05M	-309.24M	-360.37M	-412.83M
Selling & General & Admin	176.3M	230.85M	332.49M	317.42M	255.47M	273.7M	273.6M
Research & Development	176.64M	185.27M	191.49M	242.8M	207.3M	191.5M	153.89M
Other Expenses	6.52M	2.15M	4.41M	8.89M	6.77M	4.52M	3.9M
Operating Expenses	352.94M	416.13M	523.98M	560.22M	462.77M	465.2M	427.49M
Interest Expense	21.39M	54.42M	48.05M	41.14M	30.52M	29.27M	14.2M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	353.93M	419.23M	529.3M	564.43M	465.29M	466.57M	427.49M
Income Tax Expense	-290.03M	53.6M	49.35M	46.37M	6.77M	29.19M	14.27M
Shares Outstanding (Basic)	33.82M	31.86M	32.97M	31.65M	28.46M	25.05M	24.66M
Shares Outstanding (Diluted)	33.84M	31.89M	32.97M	31.65M	28.46M	25.05M	24.66M
EPS (Basic)	3.41	-4.55	-9.83	-12.35	-10.86	-14.38	-16.74
EPS (Diluted)	3.40	-4.55	-9.83	-12.35	-10.86	-14.38	-16.74
EBITDA	-61.7M	-53.6M	-212.2M	-303.54M	-278.72M	-331.1M	-398.63M
EBIT	-153.47M	-37.01M	-238.67M	-303.54M	-278.72M	-331.1M	-398.63M
Depreciation & Amortization	6.52M	2.15M	4.41M	8.89M	4.58M	4.6M	3.83M